{"id":973,"date":"1998-12-01T12:06:00","date_gmt":"1998-12-01T11:06:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1998\/oestrogen-gestagen-in-einer-randomisierten-studie-zur-postmenopausalen-sekundaerprophylaxe-der-koronaren-herzkrankheit-unwirksam"},"modified":"2022-03-17T14:09:01","modified_gmt":"2022-03-17T13:09:01","slug":"oestrogen-gestagen-in-einer-randomisierten-studie-zur-postmenopausalen-sekundaerprophylaxe-der-koronaren-herzkrankheit-unwirksam","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1998\/oestrogen-gestagen-in-einer-randomisierten-studie-zur-postmenopausalen-sekundaerprophylaxe-der-koronaren-herzkrankheit-unwirksam","title":{"rendered":"\u00d6strogen\/Gestagen in einer randomisierten Studie zur postmenopausalen Sekund\u00e4rprophylaxe der koronaren Herzkrankheit unwirksam"},"content":{"rendered":"<p>Wir haben mehrfach Nutzen und Risiken der postmenopausalen Substitution von \u00d6strogenen\/Gestagenen besprochen (AMB 1995, 29, 25; 1995, 29, 65; 1995, 29, 78; 1996, 30, 45; 1997, 31, 10). Bisher war man auf Fall-Kontroll-Studien und epidemiologische Langzeitbeobachtungen (z.B. die Nurses Health Study) angewiesen, die zeigten, da\u00df eine postmenopausale Substitution von \u00d6strogenen mit einem niedrigeren Risiko f\u00fcr [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wir haben mehrfach Nutzen und Risiken der postmenopausalen Substitution von \u00d6strogenen\/Gestagenen besprochen (AMB 1995, 29, 25; 1995, 29, 65; 1995, 29, 78; 1996, 30, 45; 1997, 31, 10). Bisher war man auf Fall-Kontroll-Studien und epidemiologische Langzeitbeobachtungen (z.B. die Nurses Health Study) angewiesen, die zeigten, da\u00df eine postmenopausale Substitution von \u00d6strogenen mit einem niedrigeren Risiko f\u00fcr [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[57,2481,2480,71,498,65,66],"class_list":["post-973","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-estrogene-gestagene","tag-gestagene-oestrogene","tag-hers-studie","tag-herzinfarkt","tag-koronare-herzkrankheit","tag-myokardinfarkt","tag-oestrogene-gestagene"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=973"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/973\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}